Header

UZH-Logo

Maintenance Infos

EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma


Weller, M; van den Bent, M; Hopkins, K; Tonn, J C; Stupp, R; Falini, A; Cohen-Jonathan-Moyal, E; Frappaz, D; Henriksson, R; Balana, C; Chinot, O; Ram, Z; Reifenberger, G; Soffietti, R; Wick, W (2014). EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncology, 15(9):e395-e403.

Abstract

This guideline provides recommendations for diagnostic and therapeutic procedures for patients with malignant gliomas. We differentiate evidence-based standards from reasonable options or non-evidence-based measures that should no longer be considered. The recommendations herein should provide a framework and assurance for the choice of diagnostic procedures and therapeutic measures and aim to reduce complications from unnecessary treatment and cost. The guideline contributes to a critical appreciation of concurrent drugs with a focus on the controlled use of anticonvulsants and steroids. It should serve as a guideline for all professionals involved in the diagnostics and care of glioma patients and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in Europe. Implementation of the recommendations summarised here will need interdisciplinary structures of care for patients with brain tumours and structured processes of diagnostic and therapeutic procedures.

Abstract

This guideline provides recommendations for diagnostic and therapeutic procedures for patients with malignant gliomas. We differentiate evidence-based standards from reasonable options or non-evidence-based measures that should no longer be considered. The recommendations herein should provide a framework and assurance for the choice of diagnostic procedures and therapeutic measures and aim to reduce complications from unnecessary treatment and cost. The guideline contributes to a critical appreciation of concurrent drugs with a focus on the controlled use of anticonvulsants and steroids. It should serve as a guideline for all professionals involved in the diagnostics and care of glioma patients and also as a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in Europe. Implementation of the recommendations summarised here will need interdisciplinary structures of care for patients with brain tumours and structured processes of diagnostic and therapeutic procedures.

Statistics

Citations

Dimensions.ai Metrics
185 citations in Web of Science®
183 citations in Scopus®
194 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 20 Aug 2014
340 downloads since 12 months

Additional indexing

Contributors:the European Association for Neuro-Oncology (EANO) Task Force on Malignant Glioma
Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:August 2014
Deposited On:20 Aug 2014 12:44
Last Modified:15 Feb 2018 00:18
Publisher:Elsevier
ISSN:1470-2045
OA Status:Green
Publisher DOI:https://doi.org/10.1016/S1470-2045(14)70011-7
PubMed ID:25079102

Download

Download PDF  'EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 328kB
View at publisher